Global Hypoparathyroidism Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G1F7336FC0B2EN
QYResearch

Abstracts

This report focuses on the global Hypoparathyroidism Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypoparathyroidism Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Takeda
• Roche
• Entera Bio
• Teva Pharmaceuticals
• Sun Pharmaceutical
• AbbVie
• GlaxoSmithKline
• Takeda Pharmaceutical

Market segment by Type, the product can be split into

• Oral
• Parenteral

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hypoparathyroidism Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hypoparathyroidism Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hypoparathyroidism Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hypoparathyroidism Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hypoparathyroidism Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral
  1.4.3 Parenteral
1.5 Market by Application
  1.5.1 Global Hypoparathyroidism Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hypoparathyroidism Treatment Market Perspective (2015-2026)
2.2 Hypoparathyroidism Treatment Growth Trends by Regions
  2.2.1 Hypoparathyroidism Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hypoparathyroidism Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hypoparathyroidism Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hypoparathyroidism Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hypoparathyroidism Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hypoparathyroidism Treatment Players by Market Size
  3.1.1 Global Top Hypoparathyroidism Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hypoparathyroidism Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hypoparathyroidism Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hypoparathyroidism Treatment Market Concentration Ratio
  3.2.1 Global Hypoparathyroidism Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hypoparathyroidism Treatment Revenue in 2019
3.3 Hypoparathyroidism Treatment Key Players Head office and Area Served
3.4 Key Players Hypoparathyroidism Treatment Product Solution and Service
3.5 Date of Enter into Hypoparathyroidism Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hypoparathyroidism Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hypoparathyroidism Treatment Forecasted Market Size by Type (2021-2026)

5 HYPOPARATHYROIDISM TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hypoparathyroidism Treatment Market Size by Application (2015-2020)
5.2 Global Hypoparathyroidism Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hypoparathyroidism Treatment Market Size (2015-2020)
6.2 Hypoparathyroidism Treatment Key Players in North America (2019-2020)
6.3 North America Hypoparathyroidism Treatment Market Size by Type (2015-2020)
6.4 North America Hypoparathyroidism Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hypoparathyroidism Treatment Market Size (2015-2020)
7.2 Hypoparathyroidism Treatment Key Players in Europe (2019-2020)
7.3 Europe Hypoparathyroidism Treatment Market Size by Type (2015-2020)
7.4 Europe Hypoparathyroidism Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hypoparathyroidism Treatment Market Size (2015-2020)
8.2 Hypoparathyroidism Treatment Key Players in China (2019-2020)
8.3 China Hypoparathyroidism Treatment Market Size by Type (2015-2020)
8.4 China Hypoparathyroidism Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hypoparathyroidism Treatment Market Size (2015-2020)
9.2 Hypoparathyroidism Treatment Key Players in Japan (2019-2020)
9.3 Japan Hypoparathyroidism Treatment Market Size by Type (2015-2020)
9.4 Japan Hypoparathyroidism Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hypoparathyroidism Treatment Market Size (2015-2020)
10.2 Hypoparathyroidism Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hypoparathyroidism Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hypoparathyroidism Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hypoparathyroidism Treatment Market Size (2015-2020)
11.2 Hypoparathyroidism Treatment Key Players in India (2019-2020)
11.3 India Hypoparathyroidism Treatment Market Size by Type (2015-2020)
11.4 India Hypoparathyroidism Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hypoparathyroidism Treatment Market Size (2015-2020)
12.2 Hypoparathyroidism Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hypoparathyroidism Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hypoparathyroidism Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Takeda
  13.1.1 Takeda Company Details
  13.1.2 Takeda Business Overview and Its Total Revenue
  13.1.3 Takeda Hypoparathyroidism Treatment Introduction
  13.1.4 Takeda Revenue in Hypoparathyroidism Treatment Business (2015-2020))
  13.1.5 Takeda Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Hypoparathyroidism Treatment Introduction
  13.2.4 Roche Revenue in Hypoparathyroidism Treatment Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Entera Bio
  13.3.1 Entera Bio Company Details
  13.3.2 Entera Bio Business Overview and Its Total Revenue
  13.3.3 Entera Bio Hypoparathyroidism Treatment Introduction
  13.3.4 Entera Bio Revenue in Hypoparathyroidism Treatment Business (2015-2020)
  13.3.5 Entera Bio Recent Development
13.4 Teva Pharmaceuticals
  13.4.1 Teva Pharmaceuticals Company Details
  13.4.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Teva Pharmaceuticals Hypoparathyroidism Treatment Introduction
  13.4.4 Teva Pharmaceuticals Revenue in Hypoparathyroidism Treatment Business (2015-2020)
  13.4.5 Teva Pharmaceuticals Recent Development
13.5 Sun Pharmaceutical
  13.5.1 Sun Pharmaceutical Company Details
  13.5.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  13.5.3 Sun Pharmaceutical Hypoparathyroidism Treatment Introduction
  13.5.4 Sun Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2015-2020)
  13.5.5 Sun Pharmaceutical Recent Development
13.6 AbbVie
  13.6.1 AbbVie Company Details
  13.6.2 AbbVie Business Overview and Its Total Revenue
  13.6.3 AbbVie Hypoparathyroidism Treatment Introduction
  13.6.4 AbbVie Revenue in Hypoparathyroidism Treatment Business (2015-2020)
  13.6.5 AbbVie Recent Development
13.7 GlaxoSmithKline
  13.7.1 GlaxoSmithKline Company Details
  13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.7.3 GlaxoSmithKline Hypoparathyroidism Treatment Introduction
  13.7.4 GlaxoSmithKline Revenue in Hypoparathyroidism Treatment Business (2015-2020)
  13.7.5 GlaxoSmithKline Recent Development
13.8 Takeda Pharmaceutical
  13.8.1 Takeda Pharmaceutical Company Details
  13.8.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  13.8.3 Takeda Pharmaceutical Hypoparathyroidism Treatment Introduction
  13.8.4 Takeda Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2015-2020)
  13.8.5 Takeda Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hypoparathyroidism Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hypoparathyroidism Treatment Revenue
Table 3. Ranking of Global Top Hypoparathyroidism Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hypoparathyroidism Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral
Table 7. Global Hypoparathyroidism Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hypoparathyroidism Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hypoparathyroidism Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hypoparathyroidism Treatment Market Share by Regions (2015-2020)
Table 11. Global Hypoparathyroidism Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hypoparathyroidism Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hypoparathyroidism Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Hypoparathyroidism Treatment Players
Table 18. Global Hypoparathyroidism Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hypoparathyroidism Treatment Market Share by Players (2015-2020)
Table 20. Global Top Hypoparathyroidism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoparathyroidism Treatment as of 2019)
Table 21. Global Hypoparathyroidism Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hypoparathyroidism Treatment Product Solution and Service
Table 24. Date of Enter into Hypoparathyroidism Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hypoparathyroidism Treatment Market Size Share by Type (2015-2020)
Table 28. Global Hypoparathyroidism Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Hypoparathyroidism Treatment Market Size Share by Application (2015-2020)
Table 30. Global Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hypoparathyroidism Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hypoparathyroidism Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hypoparathyroidism Treatment Market Share (2019-2020)
Table 34. North America Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hypoparathyroidism Treatment Market Share by Type (2015-2020)
Table 36. North America Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hypoparathyroidism Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Hypoparathyroidism Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hypoparathyroidism Treatment Market Share (2019-2020)
Table 40. Europe Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hypoparathyroidism Treatment Market Share by Type (2015-2020)
Table 42. Europe Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hypoparathyroidism Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Hypoparathyroidism Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hypoparathyroidism Treatment Market Share (2019-2020)
Table 46. China Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Hypoparathyroidism Treatment Market Share by Type (2015-2020)
Table 48. China Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Hypoparathyroidism Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Hypoparathyroidism Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hypoparathyroidism Treatment Market Share (2019-2020)
Table 52. Japan Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hypoparathyroidism Treatment Market Share by Type (2015-2020)
Table 54. Japan Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hypoparathyroidism Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hypoparathyroidism Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hypoparathyroidism Treatment Market Share (2019-2020)
Table 58. Southeast Asia Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hypoparathyroidism Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hypoparathyroidism Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Hypoparathyroidism Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hypoparathyroidism Treatment Market Share (2019-2020)
Table 64. India Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Hypoparathyroidism Treatment Market Share by Type (2015-2020)
Table 66. India Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Hypoparathyroidism Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hypoparathyroidism Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hypoparathyroidism Treatment Market Share (2019-2020)
Table 70. Central & South America Hypoparathyroidism Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hypoparathyroidism Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Hypoparathyroidism Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hypoparathyroidism Treatment Market Share by Application (2015-2020)
Table 74. Takeda Company Details
Table 75. Takeda Business Overview
Table 76. Takeda Product
Table 77. Takeda Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 78. Takeda Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Entera Bio Company Details
Table 85. Entera Bio Business Overview
Table 86. Entera Bio Product
Table 87. Entera Bio Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 88. Entera Bio Recent Development
Table 89. Teva Pharmaceuticals Company Details
Table 90. Teva Pharmaceuticals Business Overview
Table 91. Teva Pharmaceuticals Product
Table 92. Teva Pharmaceuticals Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 93. Teva Pharmaceuticals Recent Development
Table 94. Sun Pharmaceutical Company Details
Table 95. Sun Pharmaceutical Business Overview
Table 96. Sun Pharmaceutical Product
Table 97. Sun Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 98. Sun Pharmaceutical Recent Development
Table 99. AbbVie Company Details
Table 100. AbbVie Business Overview
Table 101. AbbVie Product
Table 102. AbbVie Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 103. AbbVie Recent Development
Table 104. GlaxoSmithKline Company Details
Table 105. GlaxoSmithKline Business Overview
Table 106. GlaxoSmithKline Product
Table 107. GlaxoSmithKline Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 108. GlaxoSmithKline Recent Development
Table 109. Takeda Pharmaceutical Business Overview
Table 110. Takeda Pharmaceutical Product
Table 111. Takeda Pharmaceutical Company Details
Table 112. Takeda Pharmaceutical Revenue in Hypoparathyroidism Treatment Business (2015-2020) (Million US$)
Table 113. Takeda Pharmaceutical Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hypoparathyroidism Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Hypoparathyroidism Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Hypoparathyroidism Treatment Report Years Considered
Figure 9. Global Hypoparathyroidism Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Hypoparathyroidism Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Hypoparathyroidism Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Hypoparathyroidism Treatment Market Share by Players in 2019
Figure 14. Global Top Hypoparathyroidism Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoparathyroidism Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Hypoparathyroidism Treatment Revenue in 2019
Figure 16. North America Hypoparathyroidism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Hypoparathyroidism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Hypoparathyroidism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Hypoparathyroidism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Hypoparathyroidism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Hypoparathyroidism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Hypoparathyroidism Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Takeda Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 27. Entera Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Entera Bio Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 29. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Teva Pharmaceuticals Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 31. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sun Pharmaceutical Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 33. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. AbbVie Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 35. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. GlaxoSmithKline Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 37. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Takeda Pharmaceutical Revenue Growth Rate in Hypoparathyroidism Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed